Hydrogen Cyanide Poisoning
- Author: Lewis S Nelson, MD, FACEP, FAACT, FACMT; Chief Editor: Robert G Darling, MD, FACEP more...
Background
This article addresses the management of hydrogen cyanide (HCN) poisoning. HCN (North Atlantic Treaty Organization [NATO] designation AC) is 1 of 2 cyanide chemical warfare agents[1, 2, 3] ; the other is cyanogen chloride (NATO designation CK).
Cyanide is a rapidly lethal agent when used in enclosed spaces where high concentrations can be achieved easily.[4, 5, 6, 7] In addition, because of the extensive use of cyanide in industry in the United States, this agent presents a credible threat for terrorist use.[2] Emergency physicians may also encounter cyanide casualties resulting from industrial accidents or fires.
Cyanide was first used as a chemical weapon in the form of gaseous HCN in World War I. Starting in 1915, the French military used approximately 4000 tons of cyanide, without notable success. The failure of this measure was probably attributable to the high volatility of cyanide and the inability of the 1- to 2-lb munitions used to deliver the amounts of chemical required for biologic effects.[2, 3]
The introduction of cyanogen chloride by the French in 1916 made available a compound that, being both more toxic and less volatile, was a more effective chemical agent. Other alleged military uses of cyanide include Japanese attacks on China before and during World War II and Iraqi attacks on Kurds in the 1980s.
For related information, see the Disaster Preparedness and Aftermath Resource Center.[8, 9]
Pathophysiology
Whereas liquid cyanide can be absorbed through the skin or eyes, the primary route of exposure is by inhalation or ingestion. Once absorbed, cyanide is distributed rapidly to all organs and tissues in the body. It inhibits multiple enzymes, most importantly cytochrome a3, a component of cytochrome oxidase in the electron transport chain of the mitochondria. This prevents intracellular oxygen use and the generation of cellular adenosine triphosphate (ATP), causing aerobic energy production to cease.
Hydrogen ions accumulate as they fail to combine with oxygen at the end of the electron transport chain, causing a metabolic acidosis. As anaerobic metabolism ensues, pyruvate accumulates and is converted to lactate, resulting in an elevated lactate concentration.[10]
The LCt50 (the concentration-time product capable of killing 50% of the exposed group) for HCN is 2500-5000 mg/min/m3. The lethal oral doses of HCN and cyanide salts are estimated to be 50 mg and 100-200 mg, respectively. The LD50 (the dose capable of killing 50% of the exposed group) for skin exposures is estimated to be 100 mg/kg. Vapor exposures in high concentrations (at or above the LCt50) typically can cause death in 6-8 minutes.[11]
Etiology
Causes of cyanide casualties include deliberate use as a chemical warfare agent, industrial exposures, and toxic byproducts of fires.[12, 11] Emergency physicians are unlikely to encounter casualties from HCN used as a weapon except in the setting of a terrorist attack[11] ; the other causes are more common.
Specific industrial processes involving cyanide include metal cleaning, reclaiming, or hardening; fumigation; electroplating; and photo processing.[12] Other potential sources of cyanide are fires involving plastics or synthetics, acrylic nail removers containing acetonitrile or propionitrile, and nitroprusside infusions.[12] Numerous plants (eg, apricots, apples, and bitter almonds) contain within their seeds and pits amygdalin, which can be hydrolyzed to HCN after the ingestion and may be poisonous in large quantities.[12]
Prognosis
The prognosis is good for patients who have only minor symptoms that do not necessitate the administration of antidotes.
The prognosis is poor in patients with cyanide poisoning sufficiently severe to cause cardiovascular collapse. In a mass casualty setting, these victims would be classified as expectant.
The prognosis is fair for patients with seizures or recent-onset apnea if antidotes can be administered rapidly. In a mass casualty setting, these victims would be classified as immediate.
Patient Education
It is important that patients exposed to HCN be educated about potential neurologic sequelae and the importance of follow-up evaluation.
For patient education resources, see the Bioterrorism and Warfare Center and the Poisoning Center, as well as Chemical Warfare, Personal Protective Equipment, Cyanide Poisoning, and Carbon Monoxide Poisoning.
Armstrong J. Chemical warfare. RN. Apr 2002;65(4):32-9. [Medline].
Greenfield RA, Brown BR, Hutchins JB. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. Jun 2002;323(6):326-40. [Medline].
Rosenbloom M, Leikin JB, Vogel SN. Biological and chemical agents: a brief synopsis. Am J Ther. Jan-Feb 2002;9(1):5-14. [Medline].
Baskin SI, Brewer TG. Cyanide poisoning. In: Medical Aspects of Chemical and Biological Warfare. 1997:271-286.
Morocco AP. Cyanides. Crit Care Clin. Oct 2005;21(4):691-705, vi. [Medline].
Sidell FR, Patrick WC, Dashiell TR. Cyanide. In: Jane's Chem-Bio Handbook. 1998:79-88.
USACHPPM. Cyanide. In: USACHPPM Tech Guide 244: The Medical NBC Battlebook. 1999:V-36-37.
Burda AM, Sigg T. Pharmacy preparedness for incidents involving weapons of mass destruction. Am J Health Syst Pharm. Dec 1 2001;58(23):2274-84. [Medline].
Lynch EL, Thomas TL. Pediatric considerations in chemical exposures: are we prepared?. Pediatr Emerg Care. Mar 2004;20(3):198-208. [Medline].
Baud FJ, Borron SW, Megarbane B. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. Sep 2002;30(9):2044-50. [Medline].
Musshoff F, Schmidt P, Daldrup T. Cyanide fatalities: case studies of four suicides and one homicide. Am J Forensic Med Pathol. Dec 2002;23(4):315-20. [Medline].
Brennan RJ, Waeckerle JF, Sharp TW. Chemical warfare agents: emergency medical and emergency public health issues. Ann Emerg Med. Aug 1999;34(2):191-204. [Medline].
Department of the Army. Blood agents (Cyanogens). In: Field Manual 8-285: Treatment of Chemical Agent Casualties and Conventional Military Chemical Injuries. 1995:VI-1-2.
USAMRICD. Cyanide. In: Field Management of Chemical Casualties Handbook. 1996:37-40.
USAMRICD. Cyanide. In: Medical Management of Chemical Casualties Handbook. 1999:38-58.
Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med. Sep 1993;22(9):1413-8. [Medline].
Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med. Jun 2007;25(5):551-8. [Medline].
Martin CO, Adams HP. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol. Jan 2003;60(1):21-5. [Medline].

